Prescription weight-loss care has expanded beyond the traditional clinic setting, giving eligible patients more ways to discuss medication-based treatment with healthcare professionals. GLP-1 medications are especially prominent in this area, with options that can involve weekly injections as well as oral treatments taken on a daily schedule. The right choice depends on the medication, the patient’s health profile and the recommendation of a licensed provider.
Zealthy uses an online care model in which patients complete a health assessment before a provider determines whether prescription treatment is appropriate. Its current weight-loss program can include FDA-approved medications such as Wegovy, Zepbound, Ozempic and Mounjaro when clinically appropriate, along with compounded semaglutide or tirzepatide options for eligible patients.
Zealthy Weight Loss Options
Zealthy weight loss options can vary based on medical eligibility, insurance coverage, treatment goals and the provider’s recommendation. The company’s current information indicates that many GLP-1 medications are administered as weekly injections, while oral GLP-1 options may also be available when clinically appropriate.
This means patients may have more than one possible treatment format to discuss with their provider. However, dosing frequency should not be the only consideration. The medication’s effectiveness, potential side effects, approval status, cost and suitability for the patient’s health circumstances are equally important.
How Weekly GLP-1 Injections Work
Weekly injections have become closely associated with several popular GLP-1-based weight-management medications. Semaglutide and tirzepatide injections used for chronic weight management are generally administered once per week according to the prescribed treatment schedule.
A weekly routine can be convenient because patients only need to plan for medication administration on one day each week. This may be easier for someone who finds daily medication routines difficult to maintain, although patients still need to remain consistent with their prescribed schedule.
Zealthy’s current website describes weekly injections as one of the available treatment formats and lists FDA-approved options such as Wegovy and Zepbound among medications that providers may prescribe when appropriate.
Semaglutide and Tirzepatide as Weekly Options
Semaglutide works primarily by activating the GLP-1 receptor, while tirzepatide activates both GIP and GLP-1 receptors. Both can influence appetite and food intake and may be prescribed for eligible patients as part of a comprehensive weight-management plan.
Wegovy is an FDA-approved semaglutide product for chronic weight management, while Zepbound is an FDA-approved tirzepatide product for chronic weight management in eligible patients. Other brand-name medications containing these active ingredients have different FDA-approved indications, so patients should confirm the exact product being prescribed.
Zealthy also states that eligible members may have access to compounded semaglutide or tirzepatide. These products should be distinguished from FDA-approved finished medications because compounded drugs do not undergo the same FDA premarket approval process.
What About Daily Medications?
Not every weight-management treatment requires a weekly injection. Oral medications can provide an alternative for patients who prefer a treatment that does not involve regular injections, although the specific medication and schedule depend on what has been prescribed.
Daily treatment can become part of an established routine, such as taking medication at a consistent time each day. For some patients, this may feel easier than remembering a weekly injection, while others may prefer having fewer medication days.
Zealthy notes that oral GLP-1 options may be available and prescribed when clinically appropriate. Patients should therefore discuss the available formulations with their provider rather than assuming that a particular medication or dosing schedule will be offered.
Daily Versus Weekly Treatment
The difference between daily and weekly treatment is primarily the frequency of administration, but the practical decision can involve much more than convenience. A daily medication requires consistent attention every day, whereas a weekly injection requires patients to remember a specific weekly schedule.
Some patients may prefer a weekly routine because it involves fewer administration occasions. Others may find that taking a medication at the same time every day fits naturally into an existing routine.
Neither approach should automatically be considered better. The medication itself, its approved use, the patient’s medical history and the provider’s recommendation should determine the appropriate treatment.
Medical Evaluation Comes First
Before a prescription is issued, Zealthy asks patients to complete an online consultation and provide health information that can be reviewed by a licensed provider. The provider then determines whether a GLP-1 medication or another weight-management treatment is clinically appropriate.
This evaluation is important because GLP-1 medications are prescription treatments and are not suitable for everyone. Medical history, current medications, potential contraindications and other individual factors can influence the provider’s decision.
Patients should provide complete and accurate information during the intake process so the healthcare professional has the information needed to make an appropriate treatment decision.
Why Dose Titration Matters
Many GLP-1 medications use a gradual dose-escalation process. A provider may begin treatment at a lower dose and increase it over time according to the medication’s prescribing instructions and the patient’s response.
This approach allows the healthcare professional to monitor tolerability while working toward an appropriate treatment dose. It can also help identify whether the patient is experiencing significant side effects as the dose changes.
Patients should never increase their medication independently or assume that taking more medication will automatically result in faster weight loss. Any change should be directed by the prescribing provider.
Insurance and Brand-Name Medications
Insurance coverage can significantly affect the cost of prescription weight-loss treatment. Zealthy states that its care coordination team can help eligible members explore insurance coverage for prescribed medications such as Wegovy, Zepbound, Ozempic and Mounjaro.
The amount a patient ultimately pays depends on the individual insurance plan, including factors such as formulary placement, deductibles, copayments, coinsurance and prior-authorization requirements.
Insurance coverage is not guaranteed, so patients should confirm their specific benefits before assuming a medication will be covered.
Compounded Medication as a Separate Pathway
For patients whose insurance does not cover their medication or who prefer an out-of-pocket pathway, Zealthy states that eligible members may be offered compounded semaglutide or tirzepatide.
The company currently lists compounded semaglutide starting at $151 per month and compounded tirzepatide starting at $216 per month under specified pricing arrangements. These prices can change, and eligibility and availability may vary.
Patients should understand that compounded medications are not FDA-approved finished drug products. Before beginning compounded treatment, they should confirm the formulation, dispensing pharmacy, dosage and administration instructions with their healthcare provider and pharmacist.
What the Membership Includes
Zealthy’s current Weight Loss Program lists a first-month membership price of $39. The membership includes personalized medical care, one-on-one coaching and support from the insurance coordination team, while medication is generally charged separately unless a bundled treatment option is selected.
The company also advertises Doctor + GLP-1 bundled plans in which the prescribed compounded medication is included in the monthly plan price. The current listed prices are different for semaglutide and tirzepatide, so patients should compare the complete cost of the specific pathway they are considering.
Because pricing and program structures can change, patients should verify the current terms before enrolling.
Coaching Alongside Medication
Medication is only one part of Zealthy’s weight-management approach. The company pairs eligible members with a dedicated coach and provides secure messaging so patients can remain connected to their care team.
Coaching can provide support around nutrition, physical activity, routines and accountability. This can be useful for patients who want help making lifestyle changes while following a prescription treatment plan.
The coach does not replace the medical provider. Medication selection, dosing and clinical decisions remain the responsibility of the licensed healthcare professional.
How Patients Can Decide Between Formats
Patients considering a weekly injection or daily medication should begin by asking which options are medically appropriate for them. The provider can consider the patient’s medical history, current medications, treatment goals and previous experiences with weight-management treatment.
After determining which medications are suitable, practical considerations such as dosing frequency, cost, insurance coverage and comfort with injections can be discussed.
A convenient schedule can improve adherence, but convenience should not override medical suitability.
Final Thoughts
GLP-1 weight management now includes multiple treatment formats, from familiar weekly injections to oral medications that may be taken daily. Zealthy’s current program provides eligible patients with access to different prescription pathways depending on provider evaluation, insurance coverage and individual medical needs.
Weekly semaglutide and tirzepatide injections may appeal to patients who prefer fewer administration days, while an appropriate oral treatment may be worth discussing with a provider for someone who prefers a daily medication routine. The choice should ultimately be based on the specific medication and the patient’s circumstances rather than dosing frequency alone.
Patients should also understand whether the treatment involves an FDA-approved product or a compounded medication and should review the full cost, including membership, medication and any applicable additional charges.
Before beginning GLP-1 treatment through Zealthy or another telehealth service, patients should complete the required medical evaluation, confirm the exact medication and dosage, understand how it will be supplied and maintain communication with their healthcare provider throughout treatment.
